Revamped PBS rules for COVID-19 antiviral and MenB vax now in effect
Patients aged 50-59 with one chronic condition are now eligible for the COVID-19 antiviral nirmatrelvir–ritonavir (Paxlovid) under the PBS. The PBAC recommended the expanded criteria…